Drugs in Context · 2019 · 30 citations · 17 references
MedicineHealth Services AdministrationClinical EpidemiologyHospital AdministrationPatient SafetyInpatient CareThromboembolic DiseaseThromboembolism PreventionThrombosisThrombosis PreventionVenous ThromboembolismHospital Stay DurationHospital-associated Venous ThromboembolismInpatient Venous Thromboembolism PreventionThromboprophylaxis In Critical IllnessThromboprophylaxis In General SurgeryThromboprophylaxis In Hospitalized PatientsThromboprophylaxis In Medical InpatientsVenous Thromboembolism Epidemiology
BACKGROUND: We evaluated whether the duration of hospital stay influences venous thromboembolism (VTE) prophylaxis patterns and VTE risk during hospitalization and post-discharge among patients hospitalized for acute illnesses in the USA. METHODS: Patients hospitalized for acute illnesses were identified from the US MarketScan Commercial and Medicare databases (January 1, 2012-June 30, 2015). Patients were stratified by index hospital length of stay (LOS), with study groups with 1-3 day, 4-6 day, and ≥7 day LOSs. Use of VTE prophylaxis and VTE event rates during and after hospitalization (6-month follow-up) were evaluated. RESULTS: <0.001). Proportions of patients with VTE events during the index hospitalization increased with longer hospital LOS (1-3 day LOS: 0.5%; 4-6 day LOS: 1.3%; ≥7 day LOS: 5.4%), as did proportions of patients with VTE events during the 6-month follow-up (1-3 day LOS: 2.4%; 4-6 day LOS: 2.7%; ≥7 day LOS: 4.2%). CONCLUSION: Among this study population of hospitalized acutely ill patients in the USA, VTE pharmacologic prophylaxis was underutilized, regardless of the duration of hospital stay. However, the risk for VTE events was substantial, with nearly 10% of those with a ≥7 day LOS having suffered a VTE event within 6 months.
17
Prevention of VTE in Nonsurgical Patients
Susan R. Kahn, Wendy Lim, Andrew Dunn et al. · CHEST Journal · 2012 · 2.7K citations · Full text
Alexander T. Cohen, Victor F. Tapson, Jean‐François Bergmann et al. · The Lancet · 2008 · 1.5K citations · Full text
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Alexander T Cohen, Theodore E. Spiro, Harry R. Büller et al. · New England Journal of Medicine · 2013 · 603 citations · Full text
Venous Thromboembolism Prophylaxis in Acutely Ill Hospitalized Medical Patients
Victor F. Tapson, Hervé Decousus, M Pini et al. · CHEST Journal · 2007 · 493 citations